65 related articles for article (PubMed ID: 1033226)
1. A note on single- and two-dose immunogenicity tests of inactive virus vaccine in chicks.
Slonim D; Drevo M
J Hyg Epidemiol Microbiol Immunol; 1976; 21(3):368-70. PubMed ID: 1033226
[TBL] [Abstract][Full Text] [Related]
2. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
[TBL] [Abstract][Full Text] [Related]
3. [Antibody response in subjects vaccinated with a recall dose of the Sabin or Salk type vaccine].
Squeri L; Calisto ML; Sindoni L; Mattace-Raso G
Ann Sclavo; 1973; 15(6):569-80. PubMed ID: 4369487
[No Abstract] [Full Text] [Related]
4. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
[TBL] [Abstract][Full Text] [Related]
5. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
6. Use of a combined DTP-polio vaccine in a reduced schedule.
Swartz TA; Roumiantzeff M; Peyron L; Stopler T; Drucker J; Epstein I; Leitner L; Goldblum N
Dev Biol Stand; 1986; 65():159-66. PubMed ID: 2881820
[TBL] [Abstract][Full Text] [Related]
7. Potency test of inactivated polio vaccines in guinea pigs.
Lapinleimu K; Stenvik M
Dev Biol Stand; 1981; 47():109-12. PubMed ID: 7014296
[TBL] [Abstract][Full Text] [Related]
8. Response of children to a single dose of oral or inactivated polio vaccine.
Magrath D; Bainton D; Freeman M
Dev Biol Stand; 1981; 47():223-6. PubMed ID: 7227651
[TBL] [Abstract][Full Text] [Related]
9. [Findings of virus-neutralizing antibodies against polioviruses in the population of Slovakia 9 and 12 years following introduction of immunization by attenuated polioviruses (author's transl)].
Borská K; Mayerová A; Masár I; Svanigová L; Roda J; Lukácová V
Bratisl Lek Listy; 1976 Apr; 65(4):400-6. PubMed ID: 183864
[No Abstract] [Full Text] [Related]
10. Antigenic potency of inactivated poliovirus vaccines.
Moynihan M; Petersen I
Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M
Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437
[TBL] [Abstract][Full Text] [Related]
12. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
Jarzabek Z; Kańtoch M
Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
[No Abstract] [Full Text] [Related]
13. Progress with inactivated poliovirus vaccines derived from the Sabin strains.
Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S
Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of poliovirus neutralizing antibodies. A seroepidemiologic survey of vaccinated and unvaccinated women of fertile age.
Moschen ME; Farisano G; Bonello C; Benussi G; Barbone F; Gasparini V; Trivello R
Boll Ist Sieroter Milan; 1987; 66(2):97-100. PubMed ID: 2822063
[TBL] [Abstract][Full Text] [Related]
15. Lack of adjuvant effect of the pertussis component on IPV DTP-polio vaccine in children.
Cadoz M; Montagnon B; Yvonnet B; Xueref C; Vincent-Falquet JC; Bandet R; Gibelin N
Dev Biol Stand; 1986; 65():153-8. PubMed ID: 2881819
[TBL] [Abstract][Full Text] [Related]
16. Priming after a fractional dose of inactivated poliovirus vaccine.
Resik S; Tejeda A; Sutter RW; Diaz M; Sarmiento L; Alemañi N; Garcia G; Fonseca M; Hung LH; Kahn AL; Burton A; Landaverde JM; Aylward RB
N Engl J Med; 2013 Jan; 368(5):416-24. PubMed ID: 23363495
[TBL] [Abstract][Full Text] [Related]
17. [Antigenicity determination of inactivated poliovirus--the micro-neutralization inhibition test].
Jiang SD; Pye D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Aug; 7(4):309-12. PubMed ID: 3011295
[No Abstract] [Full Text] [Related]
18. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
Yang C; Shi H; Zhou J; Liang Y; Xu H
Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
[TBL] [Abstract][Full Text] [Related]
19. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
Kuwert E; Höher PG; Thraenhart O
Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
[TBL] [Abstract][Full Text] [Related]
20. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
